158 related articles for article (PubMed ID: 15026806)
1. Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumours and metastases.
Karoui M; Tresallet C; Julie C; Zimmermann U; Staroz F; Brams A; Muti C; Boulard C; Robreau AM; Puy H; Malafosse R; Penna C; Pruvot FR; Thiery JP; Boileau C; Rougier P; Nordlinger B; Radvanyi F; Franc B; Hofmann-Radvanyi H
Br J Cancer; 2004 Mar; 90(6):1230-4. PubMed ID: 15026806
[TBL] [Abstract][Full Text] [Related]
2. PTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers.
Zhou XP; Loukola A; Salovaara R; Nystrom-Lahti M; Peltomäki P; de la Chapelle A; Aaltonen LA; Eng C
Am J Pathol; 2002 Aug; 161(2):439-47. PubMed ID: 12163369
[TBL] [Abstract][Full Text] [Related]
3. PTEN mutations are common in sporadic microsatellite stable colorectal cancer.
Nassif NT; Lobo GP; Wu X; Henderson CJ; Morrison CD; Eng C; Jalaludin B; Segelov E
Oncogene; 2004 Jan; 23(2):617-28. PubMed ID: 14724591
[TBL] [Abstract][Full Text] [Related]
4. Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers.
Goel A; Arnold CN; Niedzwiecki D; Carethers JM; Dowell JM; Wasserman L; Compton C; Mayer RJ; Bertagnolli MM; Boland CR
Cancer Res; 2004 May; 64(9):3014-21. PubMed ID: 15126336
[TBL] [Abstract][Full Text] [Related]
5. Colorectal carcinomas and PTEN/MMAC1 gene mutations.
Dicuonzo G; Angeletti S; Garcia-Foncillas J; Brugarolas A; Okrouzhnov Y; Santini D; Tonini G; Lorino G; De Cesaris M; Baldi A
Clin Cancer Res; 2001 Dec; 7(12):4049-53. PubMed ID: 11751500
[TBL] [Abstract][Full Text] [Related]
6. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis.
Howe JR; Bair JL; Sayed MG; Anderson ME; Mitros FA; Petersen GM; Velculescu VE; Traverso G; Vogelstein B
Nat Genet; 2001 Jun; 28(2):184-7. PubMed ID: 11381269
[TBL] [Abstract][Full Text] [Related]
7. Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas.
Reifenberger J; Wolter M; Boström J; Büschges R; Schulte KW; Megahed M; Ruzicka T; Reifenberger G
Virchows Arch; 2000 May; 436(5):487-93. PubMed ID: 10881743
[TBL] [Abstract][Full Text] [Related]
8. PTEN / MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas.
Fujiwara Y; Hoon DS; Yamada T; Umeshita K; Gotoh M; Sakon M; Nishisho I; Monden M
Jpn J Cancer Res; 2000 Mar; 91(3):287-92. PubMed ID: 10760687
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN.
Scarisbrick JJ; Woolford AJ; Russell-Jones R; Whittaker SJ
Blood; 2000 May; 95(9):2937-42. PubMed ID: 10779442
[TBL] [Abstract][Full Text] [Related]
10. Somatic mutation of PTEN in bladder carcinoma.
Aveyard JS; Skilleter A; Habuchi T; Knowles MA
Br J Cancer; 1999 May; 80(5-6):904-8. PubMed ID: 10360673
[TBL] [Abstract][Full Text] [Related]
11. Identification of PTEN mutations in metastatic melanoma specimens.
Celebi JT; Shendrik I; Silvers DN; Peacocke M
J Med Genet; 2000 Sep; 37(9):653-7. PubMed ID: 10978354
[TBL] [Abstract][Full Text] [Related]
12. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
Freihoff D; Kempe A; Beste B; Wappenschmidt B; Kreyer E; Hayashi Y; Meindl A; Krebs D; Wiestler OD; von Deimling A; Schmutzler RK
Br J Cancer; 1999 Feb; 79(5-6):754-8. PubMed ID: 10070865
[TBL] [Abstract][Full Text] [Related]
13. PTEN inactivation is rare in melanoma tumours but occurs frequently in melanoma cell lines.
Pollock PM; Walker GJ; Glendening JM; Que Noy T; Bloch NC; Fountain JW; Hayward NK
Melanoma Res; 2002 Dec; 12(6):565-75. PubMed ID: 12459646
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma.
Feilotter HE; Coulon V; McVeigh JL; Boag AH; Dorion-Bonnet F; Duboué B; Latham WC; Eng C; Mulligan LM; Longy M
Br J Cancer; 1999 Feb; 79(5-6):718-23. PubMed ID: 10070859
[TBL] [Abstract][Full Text] [Related]
15. Somatic mutation and homozygous deletion of PTEN/MMAC1 gene of 10q23 in renal cell carcinoma.
Alimov A; Li C; Gizatullin R; Fredriksson V; Sundelin B; Klein G; Zabarovsky E; Bergerheim U
Anticancer Res; 1999; 19(5B):3841-6. PubMed ID: 10628321
[TBL] [Abstract][Full Text] [Related]
16. Presence of allelic loss and PTEN mutations in malignant gliomas from Malay patients.
Zainuddin N; Jaafar H; Isa MN; Abdullah JM
Med J Malaysia; 2004 Oct; 59(4):468-79. PubMed ID: 15779579
[TBL] [Abstract][Full Text] [Related]
17. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
[TBL] [Abstract][Full Text] [Related]
18. Microsatellite deletion mapping on chromosome 10q and mutation analysis of MMAC1, FAS, and MXI1 in human glioblastoma multiforme.
Fults D; Pedone CA; Thompson GE; Uchiyama CM; Gumpper KL; Iliev D; Vinson VL; Tavtigian SV; Perry WL
Int J Oncol; 1998 Apr; 12(4):905-10. PubMed ID: 9499454
[TBL] [Abstract][Full Text] [Related]
19. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.
Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC
J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
